MALDI-TOF-MS analysis in low molecular weight serum peptidome biomarkers for NSCLC.
Yufan SongXiaoyu XuNana WangTing ZhangChengjin HuPublished in: Journal of clinical laboratory analysis (2022)
This study shows that the application of MALDI-TOF-MS is a promising approach for the identification of potential serum biomarkers for NSCLC, which is potentially valuable for establishing a new diagnostic method for lung cancer. In addition, we found that fibrinogen α chain may be an auxiliary diagnostic indicator for NSCLC.